The relationship between hypophosphataemia and outcomes during low-intensity and high-intensity continuous renal replacement therapy

Critical Care and Resuscitation

Volumn 16, Issue 1, 2014, Pages 34-41

  Bellomo, Rinaldo ^a   Cass, Alan ^b   Cole, Louise ^c   Finfer, Simon ^d   Gallagher, Martin ^e   Kim, Inbyung ^f   Lee, Joanne ^e   Lo, Serigne ^e   McArthur, Colin ^g   McGuinness, Shay ^g   Norton, Robyn ^e   Myburgh, John ^e   Scheinkestel, Carlos ^h  

^a Australian and New Zealand Intensive Care Research Centre   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c NEPEAN HOSPITAL   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^f AUSTIN HOSPITAL   (Australia)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE;

ADULT; ARTICLE; AUSTRALIA; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; FOLLOW UP; HUMAN; HYPOPHOSPHATEMIA; INCIDENCE; MALE; METHODOLOGY; MULTICENTER STUDY; NEW ZEALAND; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AUSTRALIA; CRITICAL ILLNESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHOSPHATEMIA; INCIDENCE; MALE; NEW ZEALAND; PHOSPHATES; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84908257707     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Geerse DA, Bindels AJ, Kuiper MA, et al. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 2010; 14: R147.
2. Kjeldsen SE, Moan A, Petrin J, et al. Effects of increased arterial epinephrine on insulin, glucose and phosphate. Blood Press 1996; 5: 27-31.
3. Brain M, Anderson M, Parkes S, Fowler P. Magnesium flux during continuous venovenous haemodiafiltration with heparin and citrate anticoagulation. Crit Care Resusc 2012; 14: 274-82.
4. Brain M, Parkes S, Fowler P, et al. Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation. Crit Care Resusc 2011; 13: 72-81.
5. Ritz E. Acute hypophosphatemia. Kidney Int 1982; 22: 84-94.
6. Aibiki M, Kawaguchi S, Maekawa N. Reversible hypophosphatemia during moderate hypothermia therapy for brain-injured patients. Crit Care Med 2001; 29: 1726-30.
7. Zazzo JF, Troché G, Ruel P, Maintenant J. High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med 1995; 21: 826-31.
8. Agusti AG, Torres A, Estopa R, Agustividal A. Hypophosphatemia as a cause of failed weaning: the importance of metabolic factors. Crit Care Med 1984; 12: 142-3.
9. Aubier M, Murciano D, Lecocguic Y, et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 1985; 313: 420-4.
10. RENAL Replacement Therapy Study Investigators; Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-38.
11. VA/NIH Acute Renal Failure Trial Network; Palevsky PM, Zhang JH, O’Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20.
12. Finfer S, Cass A, Gallagher M, et al; RENAL Study Investigators. The RENAL (Randomised Evaluation of Normal vs. Augmented Level Replacement Therapy) study: statistical analysis plan. Crit Care Resusc 2009; 11: 58-65.
13. RENAL Study Investigators. Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. Crit Care Resusc 2008; 10: 225-30.
14. RENAL Study Investigators; Bellomo R, Cass A, Cole L, et al. Design and challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: high-dose versus standard-dose hemofiltration in acute renal failure. Blood Purif 2008; 26: 407-16.
15. RENAL Replacement Therapy Trial Investigators; Bellomo R, Cass A, Cole L, et al. Screening and study enrolment in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) Replacement Therapy Trial. Blood Purif 2009; 27: 199-205.
16. Tai BC, Wee J, Machin D. Analysis and design of randomised clinical trials involving competing risk endpoints. Trials 2011; 12: 127.
17. Rizopoulos D. JM: an R package for the joint modeling of longitudinal and time-to-event data. J Stat Softw 2010; 35: 1-33.
18. Nath DC, Bhattacharjee A. Pattern mixture modeling: an application in anti diabetes drug therapy on serum creatinine in type 2 diabetes patients. Asian J Math Stat 2012; 5: 71-81.
19. Shor R, Halabe A, Rishver S, et al. Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 2006; 36: 67-72.
20. Sankaran RT, Mattana J, Pollack S, et al. Laboratory abnormalities in patients with bacterial pneumonia. Chest 1997; 111: 595-600.
21. Demirjian S, Teo BW, Guzman JA, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011; 26: 3508-14.
22. Suzuki S, Egi M, Schneider AG, et al. Hypophosphatemia in critically ill patients. J Crit Care 2013; 28: 536.e9-19.
23. Yang Y, Zhang P, Cui Y, et al. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care 2013; 17: R205.
24. Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis 2012; 60: 655-61.
25. Santiago MJ, López-Herce J, Urbano J, et al. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 2009; 75: 312-6.
26. French C, Bellomo R. A rapid intravenous phosphate replacement protocol for critically ill patients. Crit Care Resusc 2004; 6: 175-9.